Saturday, November 21, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Exports

Exports: Zydus markets Ahmedabad-made tablet in the US

Fiinews by Fiinews
April 24, 2024
in Exports
Reading Time: 2 mins read
A A
0
Zyduslogo
0
SHARES
52
VIEWS
LinkedinShare on Twitter

Mirabegron Extended-Release Tablets will strengthen growth plans in US market, says Dr Patel

Zydus Lifesciences Limited has launched Ahmedabad-made Mirabegron Extended-Release Tablets, 25 mg in the US market following approval by the United States Food and Drug Administration (USFDA) https://www.fda.gov/ .

The approval allows marketing of Mirabegron Extended-Release Tablets USP 25 mg and 50 mg (USRLD: Myrbetriq® Extended-Release Tablets), said Zydus https://www.zyduslife.com/zyduslife/ which is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market and is prepared to launch Mirabegron Extended-Release Tablets, 50mg imminently.

Mirabegron https://www.healthindiatpa.com/ is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.

The drug will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ, India https://www.makeinindia.com/ .

Speaking on the launch on 22 April 2024, CEO Americas Dr Punit Patel said, “As one of the first suppliers, we are pleased with the launch of generic Mirabegron which will improve access and availability of the generic product https://www.who.int/ for patients in the US market. This is a significant launch for us which will strengthen our growth plans in US market in the current fiscal.”

Mirabegron Extended-Release Tablets USP 25mg and 50mg had annual sales of US$2.42 billion in the US (IQVIA MAT February 2024).

The group now has 393 approvals and has so far filed over 460* ANDAs since the commencement of the filing process in FY 2003-04.

Zydus has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs. The group employs over 26,000 people worldwide, including 1,400 scientists engaged in R & D, and is driven by its mission to unlock new possibilities in lifesciences through quality healthcare solutions that impact lives. Fiinews.com

Tags: Zydus
ShareTweetShare

Related Posts

PIB
Exports

Export: India calls for AITIGA review

by Fiinews
November 21, 2026
0
16

Delegates explored cooperation in economic sectors India has highlighted the importance of an early conclusion of the ASEAN-India Trade in...

PIB
Exports

Export: India-Thailand traded $21.49bn in FY25-26

by Fiinews
November 18, 2026
0
27

Thailand presented its “Co-Creation Co-Investment” approach in Nonthaburi The India-Thailand bilateral trade reached USD21.49 billion in FY 2025–26, registering a...

PIB

Export: India-Egypt set $12bn bilateral trade target

November 18, 2026
23
Indian Business Porftal

Export: Sustain growth in shipments, says FIOE Chief

November 16, 2026
24
Bharat RE

Export: India to ship green molecules globally

November 7, 2026
29
JBM EV

Export: India-made e-bus launched in Singapore

November 4, 2026
29
SBI YONO

Recent News

  • Market: Greaves expands global marine business
  • Market: Polycab strengthens presence in US
  • Project: Diving craft delivered to Navy
  • Tech: 10cr MSMEs to remain ahead of AI curve
  • Manufacture: Paswan wants value in agriculture products

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.